on I2S (EPA:ALI2S)
I2S 2025 half-year results: a mixed context
i2S has announced revenue of €7.4 million for the first half of 2025, marking a 13% decrease compared to the same period in 2024. This decrease, although significant, is mitigated by a less unfavorable second quarter with a decline of only 6.5% compared to the first.
In detail, the i2S Medcare and i2S Orphie segments recorded increases of 15% and 17% respectively. This momentum was partially offset by a significant decline in sales of i2S DigiBook and i2S Vision, impacting the overall figure. Export activities accounted for 69% of revenue but also suffered an 18% contraction.
The positive outlook for i2S is based on strong demand for the Orphie and Twiga ranges, as well as new strategic contracts that could boost growth. However, geopolitical uncertainty remains a variable to monitor.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all I2S news